| # | Drug | Count |
|---|---|---|
| 0 | PEGFILGRASTIM | 6057 |
| 1 | ALBUTEROL SULFATE | 5485 |
| 2 | EVOLOCUMAB | 4408 |
| 3 | SOMATROPIN | 3445 |
| 4 | FLUTICASONE PROPIONATE AND SALMETEROL | 1463 |
| 5 | ERENUMAB-AOOE | 888 |
| 6 | ETANERCEPT | 811 |
| 7 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 793 |
| 8 | NEMOLIZUMAB-ILTO | 658 |
| 9 | TREPROSTINIL | 650 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM | 6057 | 0.5057 |
| 1 | SOMATROPIN | 3445 | 0.0460 |
| 2 | NEMOLIZUMAB-ILTO | 658 | 0.0413 |
| 3 | EVOLOCUMAB | 4408 | 0.0267 |
| 4 | ADALIMUMAB-ATTO | 38 | 0.0236 |
| 5 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 793 | 0.0219 |
| 6 | ALBUTEROL SULFATE | 5485 | 0.0183 |
| 7 | KETAMINE HYDROCHLORIDE | 90 | 0.0175 |
| 8 | ERENUMAB-AOOE | 888 | 0.0160 |
| 9 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 10 | 0.0129 |
| # | Drug class | Count |
|---|---|---|
| 0 | Leukocyte Growth Factor [EPC] | 6087 |
| 1 | PCSK9 Inhibitor [EPC] | 4435 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 943 |
| 3 | Prostacycline Vasodilator [EPC] | 677 |
| 4 | Interleukin-31 Receptor alpha Antagonist [EPC] | 658 |
| 5 | Progestin [EPC] | 632 |
| 6 | Progestin-containing Intrauterine System [EPC] | 580 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 492 |
| 8 | Corticosteroid [EPC] | 485 |
| 9 | Benzodiazepine [EPC] | 328 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 196 | 0.2849 |
| 1 | PCSK9 Inhibitor [EPC] | 4435 | 0.1722 |
| 2 | Leukocyte Growth Factor [EPC] | 6087 | 0.0426 |
| 3 | Interleukin-31 Receptor alpha Antagonist [EPC] | 658 | 0.0413 |
| 4 | Recombinant Human Growth Hormone [EPC] | 249 | 0.0113 |
| 5 | Provitamin D2 Compound [EPC] | 228 | 0.0077 |
| 6 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 181 | 0.0057 |
| 7 | Prostacycline Vasodilator [EPC] | 677 | 0.0049 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 9 | 0.0043 |
| 9 | Interferon alfa-2b [EPC] | 7 | 0.0038 |